Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Ključne riječi:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideSažetak
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Preuzimanja
Objavljeno
2021-02-05
Broj časopisa
Rubrika
Review Article
Licenca
Autorska prava (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema
This work is licensed under a KreativniCommons Attribution-NonCommercial Međunarodne licence.
Kako citirati
Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089
